Skip to content
★ Sign in to follow
SW

Stanley W. Peters III

Executive
Chief Executive Officer
Total declarations
67
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (21 ops.)
€7.4M

Latest filing published 17 Jun 2024 for CONMED Corp, €268k.

Filing timeline

BuySale
Stanley W. Peters III

Insider track record

Disclosed buys
0
Disclosed sells
21
Signal history

Stanley W. Peters III: trading record in brief

This profile gathers the share dealings of Stanley W. Peters III in CONMED Corp, where the filings describe the role as chief executive. Over a trading history stretching from 30 September 2015 to 14 June 2024, the count stands at 67 filings.

No open-market purchase appears, only 21 sales worth €7.4M. Besides market trades, the filings include 23 share grants and 23 option exercises. Since January 2024: no purchases and 1 sale on the market.

On 17 June 2024 came the latest disclosure, an open-market sale for €268k in CONMED Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Stanley W. Peters III

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations67 total
  • ▼
    President AS and AETExecutivesCONMED Corp
    287,280 USD22SEC
    4,000 shares@ US$71.822.7% of flowCommon StockSEC:0001127602-24-018832:1
  • ◇
    President AS and AETExecutivesCONMED Corp
    167,720 USD23SEC
    4,000 shares@ US$41.9310.0% of flowCommon StockSEC:0001127602-24-018832:0
  • ▼
    President AS and AETExecutivesCONMED Corp
    252,839 USD22SEC
    2,300 shares@ US$109.932.3% of flowCommon StockSEC:0001127602-23-028980:1
  • ◇
    President AS and AETExecutivesCONMED Corp
    96,439 USD23SEC
    2,300 shares@ US$41.935.7% of flowCommon StockSEC:0001127602-23-028980:0
  • ▼
    President AS and AETExecutivesCONMED Corp
    122,880 USD22SEC
    1,200 shares@ US$102.401.2% of flowCommon StockSEC:0001127602-23-027084:1
  • ◇
    President AS and AETExecutivesCONMED Corp
    50,316 USD22SEC
    1,200 shares@ US$41.933.0% of flowCommon StockSEC:0001127602-23-027084:0
  • ▼
    President AS and AETExecutivesCONMED Corp
    214,620 USD34SEC
    2,000 shares@ US$107.312.0% of flowCommon StockSEC:0001127602-23-024253:1
  • ◇
    President AS and AETExecutivesCONMED Corp
    83,860 USD23SEC
    2,000 shares@ US$41.935.0% of flowCommon StockSEC:0001127602-23-024253:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    655,700 USD27SEC
    5,000 shares@ US$131.146.1% of flowCommon StockSEC:0001127602-23-018442:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    209,650 USD12SEC
    5,000 shares@ US$41.9312.4% of flowCommon StockSEC:0001127602-23-018442:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    181,350 USD29SEC
    1,500 shares@ US$120.901.7% of flowCommon StockSEC:0001127602-23-016612:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    62,895 USD11SEC
    1,500 shares@ US$41.933.7% of flowCommon StockSEC:0001127602-23-016612:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    178,860 USD29SEC
    1,500 shares@ US$119.241.7% of flowCommon StockSEC:0001127602-23-016278:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    62,895 USD11SEC
    1,500 shares@ US$41.933.7% of flowCommon StockSEC:0001127602-23-016278:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    756,750 USD12SEC
    7,500 shares@ US$100.907.4% of flowCommon StockSEC:0001127602-22-020992:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    314,475 USD13SEC
    7,500 shares@ US$41.9319.5% of flowCommon StockSEC:0001127602-22-020992:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    399,600 USD23SEC
    2,700 shares@ US$148.003.6% of flowCommon StockSEC:0001127602-22-007085:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    335,440 USD11SEC
    8,000 shares@ US$41.933.0% of flowCommon StockSEC:0001127602-22-007085:2
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    952,174 USD24SEC
    6,418 shares@ US$148.368.6% of flowCommon StockSEC:0001127602-22-007085:3
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    236,288 USD23SEC
    1,582 shares@ US$149.362.1% of flowCommon StockSEC:0001127602-22-007085:4
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    107,649 USD12SEC
    2,700 shares@ US$39.876.2% of flowCommon StockSEC:0001127602-22-007085:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    2M USD32SEC
    14,000 shares@ US$154.0632.4% of flowCommon StockSEC:0001127602-21-028434:1
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    558,180 USD14SEC
    14,000 shares@ US$39.8730.8% of flowCommon StockSEC:0001127602-21-028434:0
  • ◇
    VP GM Advanced SurgeryExecutivesCONMED Corp
    239,220 USD12SEC
    6,000 shares@ US$39.875.6% of flowCommon StockSEC:0001127602-20-031505:0
  • ▼
    VP GM Advanced SurgeryExecutivesCONMED Corp
    652,200 USD31SEC
    6,000 shares@ US$108.7015.3% of flowCommon StockSEC:0001127602-20-031505:1

25 of 67 declarations